These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38560412)

  • 1. Antihypertensive medication adherence trends by sex and drug class: A pilot study.
    Holmes HR; Li Q; Xu K; Kim S; Richards EM; Keeley EC; Handberg EM; Smith SM; Raizada MK; Pepine CJ; Cooper-DeHoff RM
    Am Heart J Plus; 2021 May; 5():100023. PubMed ID: 38560412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonadherence to antihypertensive medications is related to pill burden in apparent treatment-resistant hypertensive individuals.
    Lawson AJ; Hameed MA; Brown R; Cappuccio FP; George S; Hinton T; Kapil V; Lenart J; Lobo MD; Martin U; Menon M; Nightingale A; Rylance PB; Webb DJ; Dasgupta I
    J Hypertens; 2020 Jun; 38(6):1165-1173. PubMed ID: 32371807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Pharmacy Refill Data With Chemical Adherence Testing in Assessing Medication Nonadherence in a Safety Net Hospital Setting.
    Osula D; Wu B; Schesing K; Das SR; Moss E; Alvarez K; Clark C; Halm EA; Brown NJ; Vongpatanasin W
    J Am Heart Assoc; 2022 Oct; 11(19):e027099. PubMed ID: 36193931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence.
    Siddiqui M; Judd EK; Dudenbostel T; Zhang B; Gupta P; Tomaszewski M; Patel P; Oparil S; Calhoun DA
    Hypertension; 2019 Sep; 74(3):652-659. PubMed ID: 31327263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug adherence and psychosocial characteristics of patients presenting with hypertensive urgency at the emergency department.
    Lauder L; Ewen S; Glasmacher J; Lammert F; Reith W; Schreiber N; Kaddu-Mulindwa D; Ukena C; Böhm M; Meyer MR; Mahfoud F
    J Hypertens; 2021 Aug; 39(8):1697-1704. PubMed ID: 33734143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of adherence to treatment in patients with resistant hypertension using toxicological serum analysis. A subgroup evaluation of the RESIST-POL study.
    Florczak E; Tokarczyk B; Warchoł-Celińska E; Szwench-Pietrasz E; Prejbisz A; Gosk M; Kabat M; Narkiewicz K; Januszewicz A; Kała M
    Pol Arch Med Wewn; 2015; 125(1-2):65-72. PubMed ID: 25578261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonadherence to antihypertensive medications amongst patients with uncontrolled hypertension: A retrospective study.
    Kulkarni S; Rao R; Goodman JDH; Connolly K; O'Shaughnessy KM
    Medicine (Baltimore); 2021 Apr; 100(14):e24654. PubMed ID: 33832064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct assessment of adherence and drug interactions in patients with hypertensive crisis-A cross-sectional study in the Emergency Department.
    Wallbach M; Lach N; Stock J; Hiller H; Mavropoulou E; Chavanon ML; Neurath H; Blaschke S; Lowin E; Herrmann-Lingen C; Müller GA; Koziolek MJ
    J Clin Hypertens (Greenwich); 2019 Jan; 21(1):55-63. PubMed ID: 30515967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Kronish IM; Lynch AI; Oparil S; Whittle J; Davis BR; Simpson LM; Krousel-Wood M; Cushman WC; Chang TI; Muntner P
    Hypertension; 2016 Jul; 68(1):39-45. PubMed ID: 27217410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries - United States, 2014.
    Ritchey M; Chang A; Powers C; Loustalot F; Schieb L; Ketcham M; Durthaler J; Hong Y
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(36):967-76. PubMed ID: 27632693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients.
    Hamdidouche I; Jullien V; Boutouyrie P; Billaud E; Azizi M; Laurent S
    J Hypertens; 2017 Sep; 35(9):1891-1898. PubMed ID: 28505066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication nonadherence: an unrecognized cardiovascular risk factor.
    Munger MA; Van Tassell BW; LaFleur J
    MedGenMed; 2007 Sep; 9(3):58. PubMed ID: 18092064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prevalence of Nonadherence in Patients With Resistant Hypertension: A Systematic Review Protocol.
    Bourque G; Ilin JV; Ruzicka M; Davis AS; Hiremath S
    Can J Kidney Health Dis; 2019; 6():2054358119897196. PubMed ID: 31903192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in Adherence.
    Gupta P; Patel P; Štrauch B; Lai FY; Akbarov A; Gulsin GS; Beech A; Marešová V; Topham PS; Stanley A; Thurston H; Smith PR; Horne R; Widimský J; Keavney B; Heagerty A; Samani NJ; Williams B; Tomaszewski M
    Hypertension; 2017 Nov; 70(5):1042-1048. PubMed ID: 28847892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonadherence by Serum Drug Analyses in Resistant Hypertension: 7-Year Follow-Up of Patients Considered Adherent by Directly Observed Therapy.
    Halvorsen LV; Bergland OU; Søraas CL; Larstorp ACK; Hjørnholm U; Kjær VN; Kringen MK; Clasen PE; Haldsrud R; Kjeldsen SE; Rostrup M; Fadl Elmula FEM; Opdal MS; Høieggen A
    J Am Heart Assoc; 2022 Sep; 11(18):e025879. PubMed ID: 36073648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis.
    Abegaz TM; Shehab A; Gebreyohannes EA; Bhagavathula AS; Elnour AA
    Medicine (Baltimore); 2017 Jan; 96(4):e5641. PubMed ID: 28121920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Nonadherence to Antihypertensive Treatment.
    Gupta P; Patel P; Štrauch B; Lai FY; Akbarov A; Marešová V; White CMJ; Petrák O; Gulsin GS; Patel V; Rosa J; Cole R; Zelinka T; Holaj R; Kinnell A; Smith PR; Thompson JR; Squire I; Widimský J; Samani NJ; Williams B; Tomaszewski M
    Hypertension; 2017 Jun; 69(6):1113-1120. PubMed ID: 28461599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.